Promising Liquid Biopsy Assay For Ovarian Cancer

Ovarian cancer is the 3rd most common cancer in women’s reproductive organs and it usually goes undetected until it becomes untreatable and deadly. University of Southern California researchers have now developed a liquid biopsy called OvaPrint capable of pinpointing high-grade serous ovarian cancer with an overall accuracy of 91%, a positive predictive value of 95% and a negative predictive value of 88%. The test differentiates circulating DNA from aggressive ovarian cancer from the DNA with benign origins. The test isn’t perfect, but it is an exciting first step toward developing reliable screening for one of the most dangerous cancers that befall women.

https://aacrjournals.org/clincancerres/article/doi/10.1158/1078-0432.CCR-23-1197/729529/OvaPrintT-a-cell-free-DNA-methylation-liquid
https://tinyurl.com/3yccp5bv

#ovariancancer #liquidbiopsy #ovaprint #usc #cfDNA